Videos
Press Releases
29 Jun 2021
PRESS RELEASE: European Organisation for Research and Treatment of Cancer (EORTC) and Pierre Fabre Partner to Address Treatment Gap for Stage 2 Melanoma Patients
4 Jun 2021
PRESS RELEASE: Sanofi partnering with leading academic cooperative groups to study amcenestrant in the adjuvant setting for patients with estrogen receptor positive breast cancer
20 Apr 2021
PRESS RELEASE: HSH Prince Albert II cedes Honorary Presidency of the EORTC Research Fund to HRH Princess Dina Mired
17 Feb 2021
PRESS RELEASE: Generating recommendations for the design, analysis and interpretation of patient- reported outcome (PRO) data for cancer clinical trials: the launch of SISAQOL-IMI
Latest Newsletters
News
6 Jun 2023
Full validation of the EORTC CAT Core
30 May 2023
Synthesis of minimally important differences for interpreting EORTC QLQ-C30 change scores across nine cancer types
25 May 2023
Publication of 2022 EORTC Annual Report
19 May 2023
EORTC is supporting Clinical Trials Day on 20th May
10 May 2023
Studying long-term survivors of glioblastoma may pave the way to better treatment
24 Apr 2023
Three new EORTC clinical trials funded by the EU
14 Apr 2023
Important new results from EORTC to be presented at ESTRO 2023
22 Feb 2023
HMP Global and EORTC announce partnership for the 25th annual World Congress on Gastrointestinal Cancer
31 Jan 2023
First international recommendations on the use of item libraries for patient-reported outcome measurement
30 Jan 2023
FDA Approves KEYTRUDA® (pembrolizumab) as Adjuvant Treatment Following Surgical Resection and Platinum-Based Chemotherapy for Patients with Stage IB (T2a ≥4 Centimeters), II, or IIIA Non-Small Cell Lung Cancer (NSCLC)
